Valuation: OncoTherapy Science, Inc.

Market Cap 816.49Cr 5.16Cr 4.61Cr 4.3Cr 3.9Cr 7.35Cr 499.62Cr 7.42Cr 52Cr 20Cr 253.88Cr 19Cr 19Cr P/E 2025
-8.97x
P/E 2026 -7.57x
Enterprise Value 607.59Cr 3.84Cr 3.43Cr 3.2Cr 2.9Cr 5.47Cr 371.79Cr 5.52Cr 38Cr 15Cr 188.92Cr 14Cr 14Cr EV / Sales 2025
9.03x
EV / Sales 2026 7.39x
Free-Float
88.54%
Yield 2025 *
-
Yield 2026 -
1 week-4.76%
Current month-4.76%
1 month-9.09%
3 months-4.76%
6 months-25.93%
1 week 20
Extreme 20
21
1 month 20
Extreme 20
23
Current year 18
Extreme 18
34
1 year 18
Extreme 18
34
3 years 15
Extreme 15
64
5 years 15
Extreme 15
89
10 years 15
Extreme 15
315
Manager TitleAgeSince
President 65 01/07/2022
President 50 05/12/2019
Chief Tech/Sci/R&D Officer 54 01/08/2012
Director TitleAgeSince
Director/Board Member 55 01/09/2014
Director/Board Member 50 01/06/2018
Chairman 82 01/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-4.76%-13.04%-28.57% 5.16Cr
-3.19%-3.19%+44.60%+87.98% 7.47TCr
-15.86%-16.16%+2.68%+51.09% 5.87TCr
-2.39%+0.50%+3.41%+31.33% 4.84TCr
-5.84%-8.01%+296.07%+643.62% 4.31TCr
+0.24%-0.98%+28.69%+29.38% 4.25TCr
-4.08%-3.08%-0.96%+101.24% 4.14TCr
-2.13%+1.07%+7.51%+50.31% 3.13TCr
-3.22%-4.73%-13.18%-15.59% 2.39TCr
-1.42%-8.11%-38.33%+307.12% 2.22TCr
Average -3.83%-2.84%+31.75%+125.79% 3.86TCr
Weighted average by Cap. -4.86%-1.88%+43.11%+135.33%

Financials

2025 2026
Net sales 75Cr 47.39L 42.32L 39.48L 35.86L 67.48L 46Cr 68.14L 4.74Cr 1.85Cr 23Cr 1.78Cr 1.74Cr 81Cr 51.05L 45.59L 42.53L 38.63L 72.7L 49Cr 73.4L 5.11Cr 2Cr 25Cr 1.92Cr 1.88Cr
Net income -82Cr -51.49L -45.98L -42.9L -38.97L -73.33L -50Cr -74.04L -5.15Cr -2.01Cr -25Cr -1.93Cr -1.89Cr -91Cr -57.49L -51.34L -47.9L -43.51L -81.87L -56Cr -82.67L -5.75Cr -2.25Cr -28Cr -2.16Cr -2.11Cr
Net Debt -83Cr -52.63L -47L -43.84L -39.83L -74.95L -51Cr -75.68L -5.26Cr -2.06Cr -26Cr -1.98Cr -1.93Cr -208.9Cr -1.32Cr -1.18Cr -1.1Cr -99.88L -1.88Cr -127.83Cr -1.9Cr -13Cr -5.16Cr -65Cr -4.96Cr -4.85Cr
Projected Income Statement - Annual - OncoTherapy Science, Inc.
Logo OncoTherapy Science, Inc.
OncoTherapy Science, Inc. is a Japan-based company mainly engaged in the development of drugs. The Company is involved in the development of low molecular drugs, antibody drugs and other drugs, as well as the provision and clinical development of medical candidate substances. The Company operates its business in cooperation with universities and other corporations. The Company provides its licenses to pharmaceutical manufacturers. The Company also involves in T Cell Receptor(TCR) analysis business.
Employees
46
Date Price Change Volume
08/26/08 JP¥20.00 0.00% 24,49,90,100
07/26/07 JP¥20.00 -4.76% 25,21,09,300
06/26/06 JP¥21.00 +5.00% 26,93,83,700
05/26/05 JP¥20.00 -4.76% 24,95,49,700
02/26/02 JP¥21.00 +5.00% 22,69,49,300

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - OncoTherapy Science, Inc.
  1. Stock Market
  2. Stocks
  3. 4564 Stock